Law360 ( July 18, 2008, 12:00 AM EDT) -- On March 31, 2008, the Court of Appeals for the Federal Circuit ("CAFC") issued its opinion in Ortho-McNeil Pharmaceutical Inc. v. Mylan Laboratories Inc., 520 F.3d 1358 (Fed. Cir. 2008) ("Ortho v. Mylan"), a case concerning Ortho-McNeil's blockbuster epilepsy and migraine drug, Topamax (generic name, topiramate)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.